• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NEU

NEUREN PHARMACEUTICALS LIMITED

1.31% ! $17.78
Market Cap $2.240B  !
Healthcare Biotechnology
Add to My Watchlist

Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing... Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing therapies for neurodevelopmental disorders. The Company is developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options. The Company’s product DAYBUE (trofinetide) is used to treat Rett syndrome in adults and pediatric patients two years of age and older. The United States (US) Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have both granted orphan drug designation to the Company for trofinetide in Fragile X syndrome. Its second product NNZ-2591 is in phase II clinical trials in Phelan-McDermid syndrome, Angelman syndrome, Pitt Hopkins syndrome and Prader-Willi syndrome. The Company has granted an exclusive worldwide license to Acadia Pharmaceuticals Inc. for the development and commercialization of NNZ-259 for Rett syndrome and Fragile X syndrome.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NEU
The End Game Is Now Clear 		21:03 30 14K
21:03 Last post  perthpest Comments Created with Sketch.  30  Views Created with Sketch.  14K 
NEU
Ann: Neuren adds SYNGAP1-related disorder to NNZ-2591 pipeline
2
20:15 60 24K
20:15 Last post  Grinny Comments Created with Sketch.  60  Views Created with Sketch.  24K 
NEU
Katelin’s Turn is HERE!!!
4 5 6
16:29 337 215K
16:29 Last post  Lectroid Comments Created with Sketch.  337  Views Created with Sketch.  215K 
NEU
Brisbane holders coffee. 		09/08/25 1 805
09/08/25 Last post  radar Comments Created with Sketch.  1  Views Created with Sketch.  805 
NEU
Acadia
26 27 28
09/08/25 1.6K 834K
09/08/25 Last post  mjc159 Comments Created with Sketch.  1.6K  Views Created with Sketch.  834K 
NEU
Share Price
271 272 273
09/08/25 16K 8.1M
09/08/25 Last post  Nutbar Comments Created with Sketch.  16K  Views Created with Sketch.  8.1M 
NEU
Neuren Media and Analyst Coverage
30 31 32
09/08/25 1.8K 1.0M
09/08/25 Last post  seanc Comments Created with Sketch.  1.8K  Views Created with Sketch.  1.0M 
NEU
NEU chart
38 39 40
08/08/25 2.3K 1.3M
08/08/25 Last post  Holidays Comments Created with Sketch.  2.3K  Views Created with Sketch.  1.3M 

See All Discussions arrow Created with Sketch.

Timeline

Neuren adds SYNGAP1-related disorder to NNZ-2591 pipeline
08 Aug 09:16
 
DAYBUE Q2 2025 net sales US$96.1 million up 14% from Q2 2024
07 Aug 09:51
 
Change of Director's Interest Notice - J Pilcher
22 Jul 09:30
 
Application for quotation of securities - NEU
22 Jul 09:21
 
Notification regarding unquoted securities - NEU
09 Jul 17:03
 
Application for quotation of securities - NEU
30 Jun 17:49
 
View More arrow Created with Sketch.

Featured News

AII Building assets, producing critical minerals and slashing dependency on China
right-arrow Created with Sketch.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$17.78 		Change
0.230(1.31%) 		Mkt cap ! $2.240B
Open High Low Value Volume
$17.83 $17.99 $17.35 $16.12M 911.8K

Buyers (Bids)

No. Vol. Price($)
2 11000 $17.40
 

Sellers (Offers)

Price($) Vol. No.
$17.80 10070 2
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
NEU (ASX) Chart

Top Stories

Iress Ltd leads top gainers intraday Friday as Blackstone buyout bid confirmed

Iress Ltd (ASX:IRE) has soared to the top of the top gainers' board on Friday, its share price posting a +12.2% rise in early...
Expert Exchange: Laretive's 4 key strategies to picking ASX winners In Australia, smallcap funds have seen varied inflows, with some experiencing significant growth due to strong performance and strategic investments in specific stocks. Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On ...
Gov't thumbs up for VRX Silica's Arrowsmith North to get started The Department of Mines, Petroleum, and Exploration in Western Australia has given VRX Silica (ASX:VRX) the formal go-ahead for the $65 million smallcap explorer’s Arrowsmith North Silica Sand Project in Geraldton’s Sandplain.Listen to the HotCopper podcast for in-...
RBA's inflation trick: Is the number lying to us? The Reserve Bank of Australia wants you to believe inflation is under control. But here’s the truth: That number is misleading; every time you pay rent, buy groceries or renew your insurance, it’s getting more expensive and you’re not imagining it.L...
What the hell is wrong with ASX Ltd? The hits keep coming, and now CBOE looms Despite a partial recovery in the Aussie IPO market – there are at least five currently slated – things aren't so great right now for the...

Featured News

AII Building assets, producing critical minerals and slashing dependency on China
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.